Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress.
about
Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells.Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation.Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy.Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse.Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 CascadeVagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats.Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium.Necrotic cell death in atherosclerosis.Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.PARP-1 Variant Rs1136410 Confers Protection against Coronary Artery Disease in a Chinese Han Population: A Two-Stage Case-Control Study Involving 5643 Subjects.Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.Poly (ADP-Ribose) Polymerase 1 Mediated Arginase II Activation Is Responsible for Oxidized LDL-Induced Endothelial Dysfunction
P2860
Q34023297-27529D35-A8E0-466A-9A10-0D6B2F113436Q34672088-4C07DE02-1FED-4493-96E0-B0149FBC58D9Q34796204-64904B8F-F4AB-47F4-97D2-C9E68FD4076DQ35176333-75222C57-0F10-4D07-A4D9-C1EAA6F4CC26Q35287136-B3999694-C54A-4998-A3B3-2E52A8BDA2D2Q35636955-37DDF04C-1330-4ECF-A3A2-0F7C6237227FQ35837289-01E0A4FD-46EB-44A7-8D4C-3CEEC00BCE5BQ35961020-F114AAE6-C081-4C11-A684-5FCAE8F9EA00Q36527088-4F76839B-92C6-4BE5-9B45-85D410D79E98Q36987659-234D59BD-052E-4807-BD84-07827F6A14C9Q37231719-EE4DB8C2-A758-4CFB-AA6C-135181D48986Q37879605-EBD9F1B9-B93D-4AE0-B107-BCE1478A4FC7Q38134049-88DA8A70-0383-41B3-BCF8-ABCF540B619FQ46114975-C8AB1068-7E35-4038-B679-2EF9FD291EFCQ51376719-43891FD2-48D6-4762-B861-DD9968C4D664Q58777359-DED32ABE-8FE2-4472-BFCD-0070FB08908D
P2860
Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Protective effects of PARP-1 k ...... on eNOS and oxidative stress.
@ast
Protective effects of PARP-1 k ...... on eNOS and oxidative stress.
@en
type
label
Protective effects of PARP-1 k ...... on eNOS and oxidative stress.
@ast
Protective effects of PARP-1 k ...... on eNOS and oxidative stress.
@en
prefLabel
Protective effects of PARP-1 k ...... on eNOS and oxidative stress.
@ast
Protective effects of PARP-1 k ...... on eNOS and oxidative stress.
@en
P2093
P2860
P1433
P1476
Protective effects of PARP-1 k ...... on eNOS and oxidative stress.
@en
P2093
A Hamid Boulares
Alan D Kaye
Amarjit S Naura
Bashir M Rezk
Chetan P Hans
Eric Lazartigues
Huijing Xia
Khalid Matrougui
Mourad Zerfaoui
P2860
P356
10.1371/JOURNAL.PONE.0007430
P407
P50
P577
2009-10-13T00:00:00Z